Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Schaffhausenon Mar 07, 2016 12:58pm
150 Views
Post# 24630558

RE:P2 Trial

RE:P2 Trial
The results are great. The group consisting of protocol (PP) users all showed significant primary endpoint (decreased POM [Pain on movement])!! Only when you add the lazy participants who did not follow the required dosage do you see the non-significance....OBVIOUSLY! If you don't take the treatment you won't get the result. 8/9 secondary endpoints (tenderness, ankle function, ankle swelling on days 3, 5, 8) were met as well. Only day 5 of ankle function did not meet. All of the secondary endpoints used the full analysis set (FAS) and did not need to filter down to PP. The only question is if filtering to PP would the result look better, I would hope so. Very importantly, the OABS (Overall Assessment of Benefit and Satisfaction) was a resoundingly significant result (P=0.0001 for satisfaction, P<0.0001 for benefit). great results. cheers, schaff for="" benefit).="" great="" results.="" cheers,="">
Bullboard Posts